Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ADK | P55263 | 2/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.31 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.31 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31725307 | 0.86 | LMNA (0.57) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL31725288 | 0.78 | LMNA (0.58) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL31725276 | 0.77 | LMNA (0.60) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL31725282 | 0.73 | ADK (0.39) | ADK | |
| SCHEMBL31725294 | 0.72 | LMNA (0.52) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL31725285 | 0.72 | LMNA (0.52) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL31725295 | 0.69 | LMNA (0.42) | LMNA | |
| SCHEMBL31725327 | 0.68 | LMNA (0.53) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL31725325 | 0.68 | LMNA (0.53) | LMNAP2RX3P2RX4P2RX2 | |
| SCHEMBL19379663 | 0.67 | LMNA (0.37) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235664-A1 | PURINE NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2025-11-13 | — | — | WO | disclosed |